# Northera

NDC: 67386-822
Generic name: droxidopa
Labeler / Manufacturer: Lundbeck Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20140901

FDA application: NDA203202

## Active ingredients

- DROXIDOPA: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67386-822"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67386-822
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2179f02c-48d7-48eb-8007-5ae43d8d16bc